Apple AirPods Pro 2 Now FDA-Cleared as Over-the-Counter Hearing Aid

Apple has achieved a regulatory breakthrough with its AirPods Pro 2, securing FDA approval for the device's over-the-counter hearing aid functionality just days after its initial announcement at the company's recent product launch event. This development positions the AirPods Pro 2 as the first software-based hearing aid to receive formal authorization from the US regulatory body.

The hearing aid feature forms part of a broader suite of three new health-focused capabilities now available on the AirPods Pro 2. The system continuously monitors and adjusts noise levels to protect users from harmful audio exposure, processes a clinically validated five-minute hearing assessment, and delivers prescription-grade amplification tailored to each user's specific auditory needs. Importantly, this entire suite functions through a software update, meaning owners of existing AirPods Pro 2 units can access these capabilities without purchasing new hardware.

The FDA's evaluation involved a clinical study of 118 participants with mild to moderate hearing impairment, confirming that the AirPods Pro 2 performs comparably to dedicated medical hearing devices. The study reported no adverse effects and validated the system's ability to measure amplification levels and speech understanding in noisy environments. Apple estimates that a substantial portion of individuals with undiagnosed hearing loss could now benefit from this accessible testing and correction solution.

This software-based approach offers significant cost advantages over traditional hearing aids, while maintaining regulatory compliance. The hearing aid functionality will roll out internationally across more than 100 countries in the coming months. Users with severe hearing impairment should continue seeking professional medical care, as the AirPods Pro 2 solution targets only mild to moderate conditions.